CYP3A4 and type 2 diabetes mellitus: Similarly, a patient with type 2 diabetes may show diminished CYP3A4 activities and decreased clearance of CYP3A substrates due to downregulation of CYP3A4 expression secondary to chronic inflammatory conditions [101,103].